Top Japan research institutes have started a collaborative R&D on a Nafamostat inhalation formulation for the treatment of novel corona virus infection
The company mentioned that it had been in talks with Attomarker since April to develop, design, test performance, adding that it had the ability to scale production as per demand
The WHO team will meet Chinese health officials soon to set parameters for investigating the origin of the virus and scientists are doubtful about finding the origin
Simulations of supercomputer-driven models in Japan suggest that operating commuter trains with windows open, limiting number of passengers might help reduce COVID-19 risk, which is claimed to be airborne
The study found that a harmless strain of Escherichia coli (E.Coli) bacteria provided protection against a lethal strain known as enterohemorrhagic E. coli (EHEC)